pone.0276047.s002.tif (1.55 MB)
BC2059 mechanism of action.
figure
posted on 2022-10-14, 17:33 authored by Danielle Almeida Braggio, Fernanda Costas C. de Faria, David Koller, Feng Jin, Abeba Zewdu, Gonzalo Lopez, Kara Batte, Lucia Casadei, Meng Welliver, Stephen K. Horrigan, Ruolan Han, Jeffrey L. Larson, Anne M. Strohecker, Raphael E. PollockTransducin β-like protein 1 (TBL1) recruits β-catenin to the Wnt target gene promoter. BC2059 disrupts the binding of β-catenin to TBL1, facilitating β-catenin destruction, resulting in the inhibition of the Wnt/β-catenin pathway.
(TIF)
History
Usage metrics
Categories
Keywords
novel therapeutic strategymutated dt cellsacute myeloid leukemiaex vivo desmoid cell linesdiv >< pdesmoid tumor treatmentdesmoid tumor patientscatenin target genedesmoid tumorscell viabilityvitro ctnnb1 axin2 type dtstegavivint ),taken togetherselective inhibitorresults demonstrateprotein levelspreclinical studiespharmacological inhibitionmultiple myelomalower effectdts ).common featureclinical studyclinical studiescatenin pathwaycatenin inhibitorsbinding tblassociated tbl1assessed usingalso referredalso found
